Brief: X4 Pharmaceuticals Q1 EPS USD -0.26 Vs. IBES Estimate USD -0.16
07/05/2024 11:01
May 07 (Reuters) - X4 Pharmaceuticals Q1 operating expenses USD 37.289 million. * Q1 net income USD -51.766 million * Q1 income from operations USD -37.289 million
Recent news on X4 Pharmaceuticals
See all newsBrief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
X4 Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: X4 Pharmaceuticals Q2 Operating Expenses USD 25.197 Million
X4 Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule